References
Ortonne JP, Arellano I, Berneburg M et al (2009) A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol 23(11):1254–1262. https://doi.org/10.1111/j.1468-3083.2009.03295.x
Ogbechie-Godec OA, Elbuluk N (2017) Melasma: an up-to-date comprehensive review. Dermatol Ther (Heidelb) 7(3):305–318. https://doi.org/10.1007/s13555-017-0194-1
Theodosakis N, Yoon J, Young K, Getachew E, Mostaghimi A, Semenov YR (2022) Validation of case identification for melasma using international statistical classification of diseases and related health problems. Tenth Revision Codes JAMA Dermatol 158(12):1453–1454. https://doi.org/10.1001/jamadermatol.2022.3872
Kim HJ, Moon SH, Cho SH, Lee JD, Kim HS (2017) Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. Acta Derm Venereol 97(7):776–781. https://doi.org/10.2340/00015555-2668
Funding
NA.
Author information
Authors and Affiliations
Contributions
EG, KK, AM, YS and NT contributed significantly to the conception and research design of the research. EG, KY and NT conducted data analysis and prepared Table 1 and Figure 1. EG, KK and NT played a primary role in drafting the manuscript. KY and DX assisted with data review and manuscript editing and review. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
Please refer to the conflict of interests in the Title page of the manuscript and the cover letter.
Conflict of interest
AM declares financial interest and a position on the advisory board of Fig. 1 Beauty, Inc., Eli Lilly and Company, Pfizer Inc. Hims. AM receives fees as a consultant from Digital Diagnostics, Hims and hers, Equillium, Eli Lilly, AbbVie, LEO, Concert Pharmaceuticals, and Pfizer Inc, and royalties from Concert and Eli Lilly. AM is the founder of Lucid, Inc. and receives funding from Pfizer Inc. and American Academy of Dermatology. AM is also Secretory/Treasurer of the Medical Dermatology Society. YS reports payment and/or honoraria from Incyte Corporation, Castle Biosciences, Galderma and Sanofi, and has a leadership and/or fiduciary role at the Castle Biosciences and Galderma. All other authors declare no conflict of interest.
Patient consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Getachew, E.D., Kamal, K., Young, K. et al. Racial and ethnic differences in melasma treatment patterns: a multi-institution study. Arch Dermatol Res 316, 175 (2024). https://doi.org/10.1007/s00403-024-02974-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00403-024-02974-6